SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001206774-22-001399
Filing Date
2022-05-13
Accepted
2022-05-13 17:16:03
Documents
14
Period of Report
2022-05-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT geron4061651-8k.htm   iXBRL 8-K 54878
2 2018 EQUITY INCENTIVE PLAN, AS AMENDED geron4061651-ex101.htm EX-10.1 124129
3 2014 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED geron4061651-ex102.htm EX-10.2 58047
  Complete submission text file 0001206774-22-001399.txt   458927

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gern-20220510.xsd EX-101.SCH 2950
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20220510_pre.xml EX-101.PRE 22353
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20220510_lab.xml EX-101.LAB 34240
8 EXTRACTED XBRL INSTANCE DOCUMENT geron4061651-8k_htm.xml XML 3594
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 22924003
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences